The Path Forward: Revealing the Rare Disease Patient Journey
While each rare disease individually impacts only 200,000 people or less, with 7,000 known rare...
While each rare disease individually impacts only 200,000 people or less, with 7,000 known rare...
While it feels like we’re back to a pre-pandemic sense of normal, COVID continues to be an evolving...
With the surge in RSV cases that plagued our nation’s children at record levels this fall and over...
The challenges of the COVID-19 pandemic did bring about some positive impact, accelerating the...
Historically, clinical trial data and real-world data (RWD) have existed in silos. With increasing...
A recent survey by the Deloitte Center for Health Solutions of biopharma executives and other...
The Inside Story Behind MOM, the Maternal Outcomes Masterset In the Spring of 2021, HealthVerity...
Written by Emery Niemiec I recently attended the 2022 INFORMS Business Analytics Conference and had...
In a recent HealthVerity LIVE webinar, we took an in-depth look at how the HealthVerity IPGE...
COVID-19 urgently highlighted the need for real-time data, and with it, the need to tap into a...
The problem with Zombie Data—And the critical need for Verified Data In life sciences, where real-world data (RWD) fuels research, market access, and commercial decision-making, trust in data is everything. Yet, the growing presence of Zombie Data—da...